Long Time Survey of RESPIMAT in Daily Clinical Use.
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2013
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 13 Jan 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 13 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2012 Actual patient number (361) added as reported by ClinicalTrials.gov.